Amgen's immunology drug results —The Novo Nordisk Senate hearing —Sanofi's soul-searching Read on to learn more.

If you are a holder of 23andMe, you are encouraged to submit your information at: On July 29, 2024, CEO Wojcicki submitted a non-binding proposal to 23andMe to acquire all shares of 23andMe that were ...

Me first announced in Oct. 2023 that the site had been the victim of a “credential stuffing attack,” during which hackers ...

The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.

The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...

On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...

Usually, introductory meetings with startup executives are perfunctory and fade to irrelevance within an hour. But I still ...

Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

SUNNYVALE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co., (Nasdaq: ME), a leading human genetics and preventive health ...

Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.

Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.